Success stories 02 Mayo 2024 Wie BeiGene den weltweiten Zugang zur Krebsbehandlung vorantreibt Von seinem europäischen Hauptsitz in Basel, Schweiz, arbeitet BeiGene strategisch mit Akteuren weltweit zusammen, um die onkologische Forsch...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Actualités 30 Abr 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 30 Abr 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
Success stories 23 Abr 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Success stories 02 Mayo 2024 BeiGene promuove l’accesso globale ai trattamenti antitumorali: ecco come Dalla sede europea di Basilea, in Svizzera, BeiGene collabora strategicamente con stakeholder in tutto il mondo per far progredire la ricerc...
Aktuell 06 Mayo 2024 EY meldet Plus von 53 Prozent bei Investitionen in der Schweiz Ausländische Investitionen in Europa sind 2023 um 4 Prozent gesunken. Die Investitionen in der Schweiz sind dagegen um 53 Prozent gestiegen. Das ...
Innovation Switzerland Innovation Parks Switzerland Innovation’s technology parks are the ideal location for research-oriented companies to develop their next groundbreaking or highly p...
Exemples de Réussite 02 Mayo 2024 Comment BeiGene favorise l’accès au traitement du cancer à l’échelle mondiale Depuis son siège européen à Bâle, en Suisse, BeiGene collabore de manière stratégique avec des parties prenantes dans le monde entier pour f...
News 06 Mayo 2024 EY reports growth of 53 percent for investments in Switzerland Foreign investments in Europe fell by 4 percent in 2023. However, investments in Switzerland were up by 53 percent. These findings were reported ...
News 26 Mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
Actualités 26 Mar 2024 Les Grands Titres de Suisse occidentale (Mars 2024) D’approches innovantes en matière de soins cardiaques et de plastiques durables à l’amélioration des thérapies pour les lésions de la moelle épin...
News 14 Feb 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
本社 14 Jun 2023 製薬、医療技術事業会社の欧州本部 欧州市場への参入を目指す日本のバイオ医薬品企業にとって、スイスは、欧州本部、また欧州・中東・アフリカ事業の地域統括拠点として最適な場所です。地理的なメリット、ビジネスのしやすさ、多様な人材の集積地であることなどが魅力となり、メルクセローノ、武田薬品工業、バイオジェン、ジョンソン・エンド・ジ...
Aktuell 22 Nov 2023 Empa erstellt 3D-Landkarte für Meniskustherapien An der Eidgenössischen Materialprüfungs- und Forschungsanstalt (Empa) arbeiten Biophysikerinnen daran, mit dreidimensionalen 3D-Modellen des Meni...
News 30 Ene 2024 Top Stories from Western Switzerland (January 2024) From groundbreaking advancements in agrifood and robotics to strategic economic reforms and pioneering research in space and medicine, discover W...